NEUP vs NRSN
Comparison between Neuphoria Therapeutics Inc (NEUP, Company) and NeuroSense Therapeutics Ltd (NRSN, Company).
Both NEUP and NRSN are from the Healthcare sector.
NEUP vs NRSN - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
NEUP
$24M
Winner
NRSN
$24M
Max Drawdown
NEUP
96.32%
Winner
NRSN
92.90%
Sharpe Ratio
Winner
NEUP
0.35
NRSN
-0.92
5Y Beta
NEUP
1.34
Winner
NRSN
0.62
Industry
NEUP
Biotechnology
NRSN
Biotechnology
P/E Ratio
NEUP
-1.06
Winner
NRSN
-2.14
5Y EPS CAGR
NEUP
N/A
NRSN
-17.43%
Debt to Equity
NEUP
0.00%
NRSN
0.00%
Free Cash Flow Yield
NEUP
-72.16%
Winner
NRSN
-32.25%
P/S Ratio
NEUP
1.70
NRSN
N/A
P/B Ratio
Winner
NEUP
0.81
NRSN
2.64
NEUP vs NRSN - Historical Returns
Returns include dividend reinvestment.
1M
NEUP
-8.69%
Winner
NRSN
-8.48%
3M
Winner
NEUP
-6.51%
NRSN
-13.86%
6M
Winner
NEUP
+13.42%
NRSN
-15.06%
1Y
Winner
NEUP
-36.24%
NRSN
-70.63%
5Y(CAGR)
NEUP
N/A
NRSN
-32.04%
Max(CAGR)
NEUP
-76.33%
Winner
NRSN
-32.04%
NEUP vs NRSN - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | NEUP | NRSN |
|---|---|---|
| 2026 | +12.83% | -9.60% |
| 2025 | +32.42% | -33.13% |
| 2024 | -90.59% | +50.00% |
| 2023 | N/A | -42.28% |
| 2022 | N/A | -54.31% |
| 2021 | N/A | -39.11% |
NEUP vs NRSN Drawdown Comparison
The maximum drawdown for NEUP was -96.32%, occurring on Jan 2, 2025. This drawdown has not yet recovered.
The maximum drawdown for NRSN was -92.90%, occurring on Oct 30, 2023. This drawdown has not yet recovered.
The current NEUP drawdown is -94.58%. The current NRSN drawdown is -88.68%.
| Rank | NEUP | NRSN |
|---|---|---|
| #1 | -96.32% Dec 24, 2024 - Jan 2, 2025 | -92.90% Mar 21, 2022 - Oct 30, 2023 |
| #2 | N/A | -67.08% Dec 9, 2021 - Mar 21, 2022 |
Correlation
Correlation between NEUP and NRSN is 0.44 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
0.44
-101
Select Stocks to Compare
Popular: NEUP vs SPYNRSN vs SPY
More Comparisons
Compare with similar stocks